SectorPharmaceutical
Established Date--
Listing Date24/08/1998
ExchangeNASDAQ Stock Exchange
Full-time Employees198
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressPerryville III Building, 53 Frontage Road, Suite 220, Hampton, New Jersey 08827
Business
IntroductionCelldex Therapeutics, Inc., is incorporated in Delaware. The Company is a biopharmaceutical company dedicated to exploring the science of mast cell biology and developing therapeutic antibodies that have the ability to engage the human immune system and directly affect key pathways to improve the lives of patients with severe inflammation, allergies, autoimmune and other devastating diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell-mediated diseases for which existing treatments are inadequate.
